Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease
Open Access
- 1 March 2017
- journal article
- Published by Elsevier in EuPA Open Proteomics
- Vol. 14, 1-10
Abstract
No abstract availableKeywords
Funding Information
- Federal Government of Australia under a Commercialisation Australia Grant (CAU05922)
This publication has 26 references indexed in Scilit:
- Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome AnalysisMolecular & Cellular Proteomics, 2012
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesKidney International, 2011
- Comprehensive Comparison of iTRAQ and Label-free LC-Based Quantitative Proteomics Approaches Using Two Chlamydomonas reinhardtii Strains of Interest for Biofuels EngineeringJournal of Proteome Research, 2011
- Quantitative Proteomics Analysis of Chondrogenic Differentiation of C3H10T1/2 Mesenchymal Stem Cells by iTRAQ Labeling Coupled with On-line Two-dimensional LC/MS/MSMolecular & Cellular Proteomics, 2010
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- Acid-Catalyzed Oxygen-18 Labeling of PeptidesAnalytical Chemistry, 2009
- A Simple Procedure for Effective Quenching of Trypsin Activity and Prevention of 18O-Labeling Back-ExchangeJournal of Proteome Research, 2009
- Large-Scale Multiplexed Quantitative Discovery Proteomics Enabled by the Use of an 18O-Labeled “Universal” Reference SampleJournal of Proteome Research, 2008
- Microarray methods for protein biomarker detectionThe Analyst, 2008
- Metapress | A Fast Growing Resource for Young EntrepreneursToxicologic Pathology, 2003